The tweet was deleted by the author.
But we saved everything 🙂.
Eastman Kodak is expanding its footprint in the pharmaceutical manufacturing sector by producing key starting materials (KSMs) domestically in the U.S. The company says this initiative is designed to improve speed, reliability, and compliance in supply chains.
Supported by robust technical expertise and certified quality and sustainability systems, Eastman Kodak aims to address critical needs in pharmaceutical manufacturing while promoting local production. The move aligns with broader efforts to enhance the resilience and quality standards of the U.S. pharmaceutical industry.
Eastman Kodak has recently expanded its operations through a partnership with Ateios Systems to promote capital-efficient battery manufacturing innovation, according to a previous report. The company also operates a 297,000-square-foot facility in Germany dedicated to the global distribution of SONORA printing plates, as detailed in an earlier article. These initiatives reflect Kodak's ongoing focus on technology-driven manufacturing.